moderate - Elective spine surgeries exhibit some cyclicality as patients may defer procedures during economic uncertainty, but the market is less discretionary than orthopedic joints. Hospital capital equipment budgets for surgical navigation systems are sensitive to healthcare system financial health. However, the company's growth is primarily driven by market share gains from competitive displacement rather than overall market growth, providing some insulation from macro headwinds. Medicare and commercial insurance reimbursement stability is more important than GDP growth.

Rising interest rates create multiple headwinds: (1) Higher cost of capital for a cash-burning business with $300M+ debt load increases financing costs and may necessitate dilutive equity raises; (2) Higher discount rates compress valuation multiples for unprofitable growth companies, particularly impacting the 2.8x Price/Sales multiple; (3) Hospital systems facing higher borrowing costs may reduce capital equipment purchases. The company's negative free cash flow of $100M annually makes it vulnerable to tighter financial conditions. Conversely, falling rates would ease financing pressure and support growth stock valuations.

growth - The stock attracts growth investors willing to accept near-term losses and high volatility in exchange for potential market share gains in the $3B lateral spine market. The 27% revenue growth rate and differentiated technology platform appeal to investors betting on competitive displacement of larger incumbents. However, the combination of negative margins, high debt, and recent 32% three-month drawdown suggests this is a high-risk/high-reward profile suitable for aggressive growth portfolios with long time horizons. Not appropriate for value or income investors given negative earnings and no dividend.